Please assess the completion status of the following clinical trial:

Trial Title: First Time in Man Trial for Friulimicin B

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female healthy subjects~* 18-55 years of age~* In good health~Exclusion Criteria:~* Abnormal physical findings of clinical significance at the Screening examination or baseline which would interfere with the objectives of the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Experimental arm with increasing dosage

Based on this trial design, predict the completion outcome and termination type (if applicable).